Delivery Order SPE2DR25D2101-SPE2DR26F47AM
- Not listed
- The Defense Logistics Agency awarded a $2,972.74 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Everolimus 1 mg tablets (60 count). This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-compete, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $26,343.78 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count units) on December 29, 2025, with a completion deadline of December 30, 2025. This firm fixed-price, non-set-aside contract represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (quantity 30) under a firm fixed-price contract valued at $12,749.86, with an ultimate completion date of December 12, 2025. This non-set-aside award represents a competitively awarded transaction for pharmaceutical supply supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 0.25 mg tablets (60-count unit) with a ceiling value of $10,068.17. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (quantity: 30 count) under a firm fixed price contract valued at $18,147.63, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award represents a single delivery order fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $17,318.52 delivery order to AmerisourceBergen Drug Corp for Everolimus 1 mg tablets (60 count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $45,979.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Everolimus 5 mg tablets (30-count units). The contract, with an ultimate completion date of December 22, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This award was not designated as a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Everolimus 5 mg tablets (30-count units) with a ceiling value of $52,818.78. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,772.21 to supply Everolimus 0.75 mg tablets (60-count packages) with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed price pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count) under a firm fixed-price contract valued at $5,473.37, with an ultimate completion date of November 21, 2025. This non-set-aside award was competitively procured and represents a single delivery order transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The contract will be performed at the vendor's corporate office...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47AMDelivery Order
The Defense Logistics Agency awarded a $22,122.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Everolimus 5 mg tablets (30-count supply), with an ultimate completion date of January 6, 2026. This competitively awarded, non-set-aside contract was issued on January 5, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies medications and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor agreement enables the contractor to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC represents a strategic procurement vehicle allowing flexible fulfillment of federal medical commodity needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 1/4/26 |